![](/img/cover-not-exists.png)
PCN64 COST-EFFECTIVENESS OF CABOZANTINIB FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA AFTER FAILURE OF PRIOR THERAPY IN BRAZIL
Serafini, P., Stefani, S., Nebel de Mello, A.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.188
Date:
May, 2019
File:
PDF, 382 KB
english, 2019